New DARZALEX® (daratumumab) Data from GRIFFIN Study Show High Response Rate and …

In newly diagnosed patients, constipation (41%), peripheral edema (41%), back pain (34%), asthenia (32%), bronchitis (29%), pneumonia (26%), …
Source: back pain